Clinical Trials List
Protocol NumberM19-037
Completed
2020-04-20 - 2024-11-01
Phase I
Recruiting2
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Hsiang-Fong Kao 無
- Wei-Wu Chen 無
- 徐偉勛 無
- 林季宏 無
- Chong-Jen Yu 無
- JIN-YUAN SHIH 無
- 蔡子修 無
- 許嘉林 無
- YEN-TING LIN 無
- YEN-SHEN LU 無
- 廖斌志 無
- 廖唯昱 無
- 張端瑩 無
- James Chih-Hsin Yang 無
- Jih-Hsiang Lee 無
- CHAO-CHI HO CHAO-CHI HO 無
- 楊景堯 無
- 陳怡君 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Min Liao 無
- 陳鴻仁 無
- Yao-Chung Wu 無
- Ming-Hung Tsai 無
- Te-Chun Hsia 無
- Chen-Teng Wu 無
- Liang-Chih Liu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
150 participants
